| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |